Jessica Barry

Gain insight from the experts on current and future treatment for pediatric atopic dermatitis.

In this video, Hema Sundaram, MA, MD, FAAD, highlights important safety considerations to keep in mind regarding laser-assisted drug delivery.

Botulinum toxin may help address erythema and flushing in patients with refractory rosacea, according to data presented by Hema Sundaram, MA, MD, FAAD, at the AAD Virtual Meeting Experience (VMX) on June 12.

In this video, Hema Sundaram, MA, MD, FAAD, shares pearls on fat grafting from her presentation at the AAD Virtual Meeting Experience (VMX) in June.

Expert recommends physicians turn to capabilities within EHRs to increase patient engagement during COVID-19 pandemic.

Hema Sundaram, MA, MD, FAAD, breaks down how botulinum toxin can be used to treat scars, a topic she discussed during her presentation at the AAD Virtual Meeting Experience (VMX) on June 12.

Recent report shows physician compensation, job options lacking due to COVID-19.

Due to the pandemic, researchers estimate many non-elderly Americans will lose their employer-sponsored health insurance by the end of 2020.

How can physicians ensure they get paid for telehealth visits? Elizabeth W. Woodcock, MBA, FACMPE, shares her insight in this interview.

In the final installment of our conversation with Adam Friedman, M.D., FAAD, he details what dermatologists should keep in mind when posting to social media.

In part three of our video interview with Adam Friedman, M.D., FAAD, he discusses some of the benefits and pitfalls of colleague-to-colleague engagement on social media.

In part two of our conversation with Adam Friedman, M.D., FAAD, he offers insight on which patients look for a dermatologist on social media and what types of content produce the most engagement online.

In part one of our interview with Adam Friedman, M.D., FAAD, he discusses the data from a recent survey study that examines the influence of dermatologists' social media use on attracting new patients.

In part two of our interview with Iltefat H. Hamzavi, M.D., he delves into the data from a recent article investigating the use ultraviolet germicidal irradiation (UVGI) as a method to disinfect N95 respirators for reuse during the COVID-19 pandemic.

In part one of our video interview with Iltefat H. Hamzavi, M.D., he discusses how ultraviolet germicidal irradiation is used in dermatology and how it can be used to disinfect N95 respirators to facilitate reuse during the COVID-19 pandemic.

Dermatology patients are hungry for information that will ensure their safety during the COVID-19 pandemic, notes Vivian Shi, M.D. In this video, she discusses how to address patients' varying concerns in this uncertain time.

In the final installment of our interview with Amy Paller, M.D., she explains the similarities and differences between Kawasaki disease and the novel condition, multisystem inflammatory syndrome in children (MIS-C).

Part three of our interview with Amy Paller, M.D., focuses on the emergence of a multisystem inflammatory syndrome in children (MIS-C), what we know about this novel condition and its relationship to COVID-19.

In light of the ongoing pandemic, Vivian Shi, M.D., discusses potential risks dermatologists will want to keep in mind when evaluating patients currently taking immunomodulator or immunosuppressant drugs.

In part two of our interview with Amy Paller, M.D., she describes how she is staying informed about the latest COVID-19 research as it relates to the field, and shares some resources other dermatologists may find helpful during this crisis.

Amy Paller, M.D., discusses the pernio-like lesions associated with possible COVID-19 infection in younger individuals.

Jonathan Silverberg, M.D., Ph.D., MPH, discusses criteria to keep in mind when evaluating a patient with possible atopic dermatitis.

Betsy Wernli, M.D., board-certified dermatologist and president of Forefront Dermatology, shares the unique ways that her practice has adapted care during the pandemic.

This week, we spoke with Mark Lebwohl, M.D., about his recent article featured in the Journal of the American Academy of Dermatology regarding biologic use in dermatology patients during the COVID-19 pandemic.

George Martin, M.D., dermatologist and program director for the Maui Derm meetings, has been working with the Maui Derm faculty, immunologists and members of industry to share emerging data regarding the novel coronavirus with the dermatology community. Listen to his insights in this video.

Jules Lipoff, M.D., dermatologist and assistant professor of clinical dermatology, Penn Medicine, discusses telemedicine in the era of COVID-19.

Verrica released positive data from its post-hoc pooled analysis of pivotal phase 3 trials investigating the safety and efficacy of VP-102 for the treatment of molluscum contagiosum.

Pediatric patients with psoriasis who experience a significant improvement in disease severity after treatment may experience the greatest positive impact to quality of life, according to a recent study. 

Eli Lilly has announced its plan to acquire Dermira, a biopharmaceutical company that specializes in developing drugs to treat a variety of skin conditions, according to a recent press release published January 10, 2010.